Recruiting Cardiomyopathy Studies in Philadelphia
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events * Evaluate the efficacy of nucresiran compare...
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
This is a first-in-human, non-randomized, open-label study designed to evaluate the safety, tolerability, and pharmacodynamics (PD) of TN-201 in adult patients with symptomatic hypertrophic cardiomyop...
About Cardiomyopathy Clinical Trials in Philadelphia
Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated, hypertrophic, and restrictive cardiomyopathy. Treatment depends on the type and may include medications, devices, or heart transplant.
There are currently 2 cardiomyopathy clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 1,280 participants. Research is being sponsored by Alnylam Pharmaceuticals, Tenaya Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cardiomyopathy Clinical Trials in Philadelphia — FAQ
Are there cardiomyopathy clinical trials in Philadelphia?
Yes, there are 2 cardiomyopathy clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What cardiomyopathy treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for cardiomyopathy.
Data updated March 2, 2026 from ClinicalTrials.gov